Acadia pharmaceuticals reports first quarter 2021 financial results

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad), today announced its financial results for the first quarter ended march 31, 2021. “nuplazid delivered strong year-over-year performance in the first quarter of 2021. looking ahead, we see positive signs in the parkinson's disease psychosis market supporting revenue growth for the remainder of the year as we anticipate continued improvements in the conditions related to the pandemic,” said steve davis, chief executive office
ACAD Ratings Summary
ACAD Quant Ranking